09:23 AM EDT, 04/12/2024 (MT Newswires) -- David S. Grayzel, Director, on April 09, 2024, sold 11,882 shares in Aerovate Therapeutics ( AVTE ) for $334,478. Following the Form 4 filing with the SEC, Grayzel has control over a total of 1,799,232 shares of the company, with 1,799,232 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1798749/000141588924010709/xslF345X03/form4-04112024_100452.xml